A Practical Guide to Immunoassay Method ValidationUlf Andréasson, Charlotte E. Teunissen, Tormod Fladby et al.|Frontiers in Neurology|2015Cited by 541
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progressionFilip Liebsch, Gerhard Multhaup, Luka Kulic et al.|Nature Communications|2019Cited by 62
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J. Bateman, Bruno Dubois, Yan Li et al.|The Lancet Neurology|2025Cited by 39